AS

Andrew Stephens

Cleo Diagnostics Ltd | Chief Scientific Officer, Executive Director
Dr Stephens has over 20 years of experience in molecular and cellular biology research. He has experience in academic and pre-clinical research, and a strong focus on translation and the commercialisation of research findings. He established and leads an independent academic research company at the Hudson Institute of Medical Research. He is also involved across the biotech sector, with appointments to the scientific advisory for Invion Pty Ltd and AMTBio Pty Ltd. Dr Stephens has over 60 academic publications and numerous patents (pending and provisional) in the cancer therapeutic and diagnostic space.

Company and Roles

Company
Title
Tenure
Since
COV
COV
Cleo Diagnostics Ltd
  • Chief Scientific Officer
  • Executive Director
4yrsSep 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
COV
COV
Cleo Diagnostics Ltd
24/08/26636,364500,0001,363,636N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
COV
COV
Cleo Diagnostics Ltd
24/08/26
Exercise
136,364$0.340$46,363Exercise of options
COV
COV
Cleo Diagnostics Ltd
24/08/26
Exercise
136,364$0.340$46,363Exercise of options
COV
COV
Cleo Diagnostics Ltd
24/08/26
Expiry
1,363,636$0.340$463,636Options expired